{"schema_version":"1","generated_at":"2026-11-04T00:12:36.272Z","data_as_of":"2026-11-03","url":"https://www.findmykol.com/kol/robert-dillman","json_url":"https://www.findmykol.com/kol/robert-dillman/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"robert-dillman","name":"Robert Dillman","credential":"MD","title":"Chief Medical Officer, AIVITA Biomedical","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Melanoma","therapeutic_areas":["Melanoma","Lymphoma","Genitourinary","Leukemia","Myeloma","Neuro-Oncology","Gastrointestinal","Lung","Gynecologic"],"institution":"AIVITA Biomedical","institution_url":"https://www.findmykol.com/institution/aivita-biomedical","city":"Newport Beach","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1538225438","openalex":"A5109971707"},"summary":"Robert Dillman is Chief Medical Officer, AIVITA Biomedical at AIVITA Biomedical. OpenAlex indexes 34 publications with 1,576 citations (h-index 14); ClinicalTrials.gov lists 23 registered studies with this person as an investigator.","overview":{"text":"Robert O. Dillman, MD FACP, is Chief Medical Officer, AIVITA Biomedical. The public record shows 34 publications with 1,576 citations (h-index 14), centered on Melanoma, Lymphoma, Kidney Cancer / RCC. It also documents an investigator role on 23 registered clinical trials, 3 NIH-funded awards (1985–1989).","bullets":["Top research focus: Melanoma","23 registered trials on ClinicalTrials.gov"],"generated_at":"2026-11-03"},"focus":{"indications":[{"label":"Melanoma","therapeutic_area":"Oncology","trials":8,"topics":0,"strength":25},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":5,"topics":0,"strength":16},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":10},{"label":"Kidney Cancer / RCC","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":10},{"label":"Kidney Neoplasms","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Multiple Myeloma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Central Nervous System Neoplasms","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Nervous System Neoplasms","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":2,"topics":0,"strength":6},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":4},{"label":"Gastroesophageal Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":4},{"label":"MDS / MPN","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Myeloproliferative Disorders","therapeutic_area":"Hematology","trials":1,"topics":0,"strength":3},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Uterine Cervical Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Esophageal Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Skin Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Penile Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Bladder / Urothelial Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Pancreatic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Colorectal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1}],"research_topics":["Melanoma","Lymphoma","Kidney Cancer / RCC","Kidney Neoplasms","Leukemia (AML/ALL/CML/CLL)","Central Nervous System Neoplasms","Multiple Myeloma","Nervous System Neoplasms","Neuro-Oncology / Glioma","Esophageal Neoplasms","Gastroesophageal Cancer","Head & Neck Cancer","Lung Cancer (NSCLC/SCLC)","MDS / MPN","Ovarian / Gynecologic Cancer","Penile Neoplasms","Skin Neoplasms","Uterine Cervical Neoplasms"],"works_with":{"total":3,"shown":3,"withheld":0,"rows":[{"name":"Hoag Memorial Hospital Presbyterian","trials":13,"payments":0,"mentions":13},{"name":"Aivita Biomedical, Inc.","trials":6,"payments":0,"mentions":6},{"name":"Lisata Therapeutics, Inc.","trials":4,"payments":0,"mentions":4}]}},"scholarship":{"works_count":34,"cited_by_count":1576,"h_index":14,"source":"works"},"trials":{"count":23,"shown":3,"withheld":20,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT05100641","title":"AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM","phase":"PHASE3","status":"NOT_YET_RECRUITING","role":"Investigator","sponsor":"Aivita Biomedical, Inc.","source_url":"https://clinicaltrials.gov/study/NCT05100641","trial_url":"https://www.findmykol.com/trial/NCT05100641"},{"nct":"NCT04690387","title":"Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection","phase":"PHASE1","status":"COMPLETED","role":"Investigator","sponsor":"Aivita Biomedical, Inc.","source_url":"https://clinicaltrials.gov/study/NCT04690387","trial_url":"https://www.findmykol.com/trial/NCT04690387"},{"nct":"NCT04386252","title":"Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults","phase":"PHASE1/PHASE2","status":"WITHDRAWN","role":"Investigator","sponsor":"Aivita Biomedical, Inc.","source_url":"https://clinicaltrials.gov/study/NCT04386252","trial_url":"https://www.findmykol.com/trial/NCT04386252"}],"source":"trials"},"payments":{"company_count":0,"program_years":{"first":2021,"last":null},"rows_total":0,"shown":0,"withheld":0,"rows":[],"record_url":"https://openpaymentsdata.cms.gov/search?query=1538225438","source":"payments"},"funding":{"award_count":3,"fiscal_years":{"first":1985,"last":1989},"rows_total":4,"shown":3,"withheld":1,"rows":[{"project":"M01RR000833","title":"IL-2/IL-2/LAK IN RENAL CELL CANCER","fiscal_year":1989,"organization":"SCRIPPS CLINIC AND RESEARCH FOUNDATION","source_url":"https://reporter.nih.gov/quickSearch/M01RR000833"},{"project":"M01RR000827","title":"PHASE I-II TRIAL OF MURINE MONOCLONAL ANTIBODY T101","fiscal_year":1985,"organization":"UNIVERSITY OF CALIFORNIA SAN DIEGO","source_url":"https://reporter.nih.gov/quickSearch/M01RR000827"},{"project":"P01CA037497","title":"CORE--PATIENT SUPPORT","fiscal_year":1985,"organization":"UNIVERSITY OF CALIFORNIA SAN DIEGO","source_url":"https://reporter.nih.gov/quickSearch/P01CA037497"}],"source":"grants"},"publications":{"total":0,"shown":0,"withheld":0,"recent":[],"most_cited":{"total":34,"shown":5,"withheld":29,"rows":[{"title":"Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial","year":1996,"cited_by_count":923,"type":"article","source_url":"https://doi.org/10.1093/jnci/88.17.1210"},{"title":"Antibodies as cytotoxic therapy.","year":1994,"cited_by_count":123,"type":"article","source_url":"https://doi.org/10.1200/jco.1994.12.7.1497"},{"title":"Recombinant Interleukin-2 and Adoptive Immunotherapy Alternated With Dacarbazine Therapy in Melanoma: A National Biotherapy Study Group Trial","year":1990,"cited_by_count":71,"type":"article","source_url":"https://doi.org/10.1093/jnci/82.16.1345"},{"title":"Toxicities and side effects associated with intravenous infusions of murine monoclonal antibodies.","year":1986,"cited_by_count":67,"type":"article","source_url":"https://openalex.org/A5109971707"},{"title":"Perceptions of Herceptin®: A Monoclonal Antibody for the Treatment of Breast Cancer","year":1999,"cited_by_count":55,"type":"article","source_url":"https://doi.org/10.1089/cbr.1999.14.5"}]},"source":"works"},"network":{"coauthors_total":32,"shown":3,"withheld":29,"coauthors":[{"name":"Shankar K. Nayak","coauthored_works":6},{"name":"Neil M. Barth","coauthored_works":5},{"name":"Linda D. Beutel","coauthored_works":5}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/robert-dillman-md","status":"verified"}]},"mentions":{"total":1,"shown":1,"rows":[{"url":"https://aivitabiomedical.com/?p=4845","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"Medical degree (M.D.), Baylor College of Medicine","source_url":"https://aivitabiomedical.com/?p=4845","status":"verified","collected_at":"2026-11-03"},{"value":"Undergraduate degree, Stanford University","source_url":"https://aivitabiomedical.com/?p=4845","status":"verified","collected_at":"2026-11-03"}]},"roles":{"total":8,"shown":3,"rows":[{"value":"Executive Medical Director, Hoag Family Cancer Institute (2008-2011)","source_url":"https://aivitabiomedical.com/?p=4845","status":"verified","collected_at":"2026-11-03"},{"value":"Medical Director, Hoag Cancer Center (1989-2008)","source_url":"https://aivitabiomedical.com/?p=4845","status":"verified","collected_at":"2026-11-03"},{"value":"Grace E. Hoag Endowed Chair of Oncology (2008)","source_url":"https://aivitabiomedical.com/?p=4845","status":"verified","collected_at":"2026-11-03"}]},"awards":{"total":3,"shown":3,"rows":[{"value":"Distinguished Service Award (2010), awarding body not named on source","source_url":"https://aivitabiomedical.com/?p=4845","status":"provisional","collected_at":"2026-11-03"},{"value":"Orange County Physician of the Year (2006)","source_url":"https://aivitabiomedical.com/?p=4845","status":"provisional","collected_at":"2026-11-03"},{"value":"Best Doctors in America (first Orange County physician selected in hematology)","source_url":"https://aivitabiomedical.com/?p=4845","status":"provisional","collected_at":"2026-11-03"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Clinical Professor of Medicine, University of California, Irvine","source_url":"https://www.terrapinn.com/conference/world-vaccine-immunotherapy-congress-west-coast/speaker-robert-DILLMAN.stm","status":"provisional","collected_at":"2026-11-03"}]}},"similar":[{"name":"Jedd Wolchok","slug":"jedd-wolchok","institution":"Weill Cornell Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jedd-wolchok","json_url":"https://www.findmykol.com/kol/jedd-wolchok/profile.json"},{"name":"Frank Hodi","slug":"frank-hodi","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/frank-hodi","json_url":"https://www.findmykol.com/kol/frank-hodi/profile.json"},{"name":"Keith Flaherty","slug":"keith-flaherty","institution":"Massachusetts General Hospital","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/keith-flaherty","json_url":"https://www.findmykol.com/kol/keith-flaherty/profile.json"},{"name":"Omid Hamid","slug":"omid-hamid","institution":"The Angeles Clinic and Research Institute","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/omid-hamid","json_url":"https://www.findmykol.com/kol/omid-hamid/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":20,"funding":1,"network":29}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-03"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-03"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-11-03"}},"methodology_url":"https://www.findmykol.com/about#methodology"}